The Bad Seed in mice. Additionally, they crossed the Aβ42-expressing Alzheimer's Disease mice with the Tg2576 mouse model of AD. These bigenic Aβ42-Tg2576 mice have a massive increase in the amount of amyloid that is deposited in the brain.
synaptic deficits long before the formation amyloid deposits, possibly due to overexpression of APP or higher levels of soluble Aβ. Overexpression of human APP leads not only to increased levels of Aβ but also to an increase in a variety of APP C-and N-terminal fragments that can have biological effects. Whether soluble Aβ plays a role in these early deficits found in these models prior to Aβ aggregation has not been definitively answered. The authors report that their new model has no obvious behavioral abnormalities, although the behavioral abnormalities observed in other AD mouse models thus far require testing in complex learning and memory paradigms to fully appreciate (Janus and Westaway, 2001). Should the Aβ42-overexpressing mice develop age-and amyloid-dependent cognitive decline, they will prove extremely valuable in further experiments to specifically test the role of soluble and insoluble forms of Aβ in both neurodegeneration and cognition. Those interested in Aβ metabolism should find these mice very useful, and we anxiously await the studies that will stem from the use of these new mouse models. 
